MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA)
MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA)
Recruiting · NCT05937958 · Registry updated 2023-07-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive organ cancer, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Not stated | 2023-07-18 | NCT05937958 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Odense University Hospital | 253 |
| UMC Utrecht | 140 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Odense University Hospital | Odense | Denmark | 57 |
| UMC Utrecht | Utrecht | Netherlands | 42 |